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Krabbe Disease (KD) is a lysosomal storage disorder characterized by the genetic
deficiency of the lysosomal enzyme β-galactosyl-ceramidase (GALC). Deficit or a
reduction in the activity of the GALC enzyme has been correlated with the progressive
accumulation of the sphingolipid metabolite psychosine, which leads to local disruption
in lipid raft architecture, diffuse demyelination, astrogliosis, and globoid cell formation.
The twitcher mouse, the most used animal model, has a nonsense mutation, which
limits the study of how different mutations impact the processing and activity of GALC
enzyme. To partially address this, we generated two new transgenic mouse models
carrying point mutations frequently found in infantile and adult forms of KD. Using
CRISPR-Cas9 gene editing, point mutations T513M (infantile) and G41S (adult) were
introduced in the murine GALC gene and stable founders were generated. We show
that GALCT 513M/T 513M mice are short lived, have the greatest decrease in GALC
activity, have sharp increases of psychosine, and rapidly progress into a severe and
lethal neurological phenotype. In contrast, GALCG41S/G41S mice have normal lifespan,
modest decreases of GALC, and minimal psychosine accumulation, but develop adult
mild inflammatory demyelination and slight declines in coordination, motor skills, and
memory. These two novel transgenic lines offer the possibility to study the mechanisms
by which two distinct GALC mutations affect the trafficking of mutated GALC and modify
phenotypic manifestations in early- vs adult-onset KD.
Keywords: galactosylceramidase, demyelination, synapses, lysosome, autophagy
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(Wenger et al., 1997) and G41S, present in many adult patients
(Lissens et al., 2007), to generate knock in mouse models. This
report presents the characterization of GALCT 513M/T 513M and
GALCG41S/G41S transgenic mice, which recapitulate early-onset
(GALCT 513M/T 513M ) and late-onset (GALCG41S/G41S ) KD forms.

INTRODUCTION
Krabbe disease (KD) is a neuropathic lysosomal storage
disease caused by deficiency of the enzyme β-galactosylceramidase (GALC) (Suzuki and Suzuki, 1970). Loss-of-function
of GALC blocks the lysosomal hydrolysis of galactosylceramides
(GalCer) and galactosylsphingosine (psychosine) (Suzuki and
Suzuki, 1970; Igisu and Suzuki, 1984; Kobayashi et al., 1987;
Greiner-Tollersrud and Berg, 2000/2013; Wenger, 2001). KD
is primarily a childhood disease with most patients presenting
neurological symptoms soon after birth. Krabbe infants can
develop irritability, spasticity, seizures, muscle weakness, and
a progressive loss of motor and cognitive functions (Escolar
et al., 2016). Late-onset forms of the disease develop usually
beyond 7–10 years of age, are less frequent, and characterized by
vision problems, walking difficulties, and cognitive deterioration
(Graziano and Cardile, 2015). The abnormal buildup of
psychosine in the central and peripheral nervous systems is
considered the main contributor to neuropathology in infantile
severe forms of KD. Psychosine promotes demyelination (Taniike
and Suzuki, 1994; Suzuki and Taniike, 1995; O’Sullivan and Dev,
2015), gliosis and inflammation (Giri et al., 2002), disruption of
lipid rafts (White et al., 2009; Hawkins-Salsbury et al., 2013),
neuropathy (Castelvetri et al., 2011, 2013; Smith et al., 2011;
Cantuti-Castelvetri et al., 2012, 2015), and alterations in many
signal transduction pathways (Giri et al., 2008; Castelvetri et al.,
2013; Sural-Fehr et al., 2019). While the pathogenic role of
psychosine in infantile KD is well documented, its contribution
to neuropathology in adult forms of KD is poorly understood,
primarily due to the lack of adult-onset KD animal models and
mechanistic studies in patients with this form of the disease.
The most widely used KD animal model is the Twitcher
(TWI) mouse, in which a naturally occurring mutation leads to
degradation of GALC mRNA and absence of functional GALC
protein (Duchen et al., 1980; Lee et al., 2006). The TWI mouse is a
surrogate model of KD, with many hallmarks observed in human
patients with infantile KD. These include toxic accumulation of
psychosine, ataxic gait deficits, muscular weakness, hind limb
paralysis, and are short life span. Other animal models, including
the globoid cell leukodystrophy (GLD) dog, the non-human
primate, and various murine lines (Bradbury et al., 2020), also
largely model severe forms of KD. There are no described animal
models of adult-onset KD.
To contribute to the study of neuropathic mechanisms of
disease in KD, particularly those at play in adult-onset forms,
we used CRISPR-Cas9 gene editing to introduce early infantile
and adult-onset KD point mutations in the GALC gene. Over
140 mutations and polymorphisms in the GALC gene have
been described (Wenger et al., 1997; Tappino et al., 2010;
Graziano and Cardile, 2015) with the 30 kb deletion of exons
10–17 being frequently found in severe infantile forms. Previous
in vitro studies showed how several point mutations in the
GALC gene, found in homozygous as well as in compound
heterozygous patients, can affect not only GALC activity but also
its trafficking to the lysosomes (Lee et al., 2010; Shin et al., 2016;
Irahara-Miyana et al., 2018). Based on this, we have selected
point mutations T513M, present in many infantile patients
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MATERIALS AND METHODS
CRISPR Mouse Construction: Zygote
Injection of CRISPR Guide RNA, Cas9
RNA, and Homology Directed Repair
Single Strand DNA Oligo Template
All procedures involving animals were conducted in accordance
with protocols approved by the Animal Care and Use Committee
at the University of Illinois at Chicago (Protocol Number 15101). CRISPR reagents were produced at the UIC Genome
Engineering Core Facility. We use the legacy nomenclature for
identifying mutations.

sgRNA Plasmid Construction
Two Cas9-sgRNA expression plasmids were constructed
by ligating oligonucleotide duplex with the forward
sequence 50 -GTCTAGCACGTAGGCGCCAC-30 and 50 GAACTTGGCGCAGCGTGAAG-30 into BsaI cut addgene
plasmid DR274, which was a gift from Keith Joung (Addgene
plasmid #42250). The sgRNA target sequences were designed to
target the GALC gene near codons G41 and T528, respectively
using the MIT CRISPR design algorithm.

Homology Directed Repair Donor Construction
A single strand oligo consisting of 70 bp homology arms flanking
the two desired mutations G41S and T528M was synthetized
(IDT). The Sequences were as follows:

ssODN Donor Mutation G41S: GGC->AGC (Bold)
50 -TGACCGCCGCCGCGGGCTCGGCGAGCCGTGTTGCGG
TGCCCTTATTGTTGTGTGCGCTGCTAGTGCCTGGTAGCG
CCTACGTGCTAGACGACTCCGACGGGCTGGGCCGGGAG
TTCGATGGCATCGGCGCAGTCAGCGGCGGCGGG-30

ssODN Donor Mutation T513M: ACG->ATG (Bold)
50 -GCTCCGAATTTTGCTGATCAGACTGGCGTGTTTGAGT
ACTACATGAATAATGAAGACCGTGAGCAACGCTTCATGC
TGCGCCAAGTTCTCAACCAACGACCTATTACCTGGGCTG
CAGACGCTTCCAGCACAATCAGTGTT-30

Guide RNA Production and Validation
In vitro transcription of RNA was performed using the
MEGAshortscriptTM T7 Transcription Kit. RNA function was
validated with an in vitro cas9 Digestion assay in which
the target region DNA was amplified from black 6 mouse
genomic DNA and allowed to incubate with cas9 nuclease
protein from NEB (M0386T) and the transcribed Guide RNA.
Mutations were confirmed by next generation sequencing before
zygote injections.
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Mouse Zygote Injections

TCCTCCCTTTAGATTATGCCAGTTTGAAGATAATTGCGG
TCAGAGAAATCCAACTTTAATGGGAAAATTGAGG-30

Injection of CRISPR reagents was performed at University of
Chicago Transgenic Core following the protocol as described
(Wang et al., 2013). Pups were genotyped at UIC using a next
generation amplicon sequencing technique which is able to
quantify the efficiency of the CRISPR edits in each individual
mouse (Cong et al., 2013; Hsu et al., 2013).

T513M Donor Template
50 GCTCCGAATTTTGCTGATCAGACTGGCGTGTTTGAGT
ACTACATGAATAATGAAGACCGTGAGCAaCGCTTCAtGCT
GCGCCAAGTTCTCAACCAACGACCTATTACCTGGGCTGC
AGACGCTTCCAGCACAATCAGTGTT-30
SduI restriction enzyme site was created when the mutation
was made, which can be used to screen mice. PAM site was
mutated to avoid cutting donor template by guide (Silent
mutation H = CAC –> H = CAa).

Generation of Transgenic Mice
Key: Gray is exon sequence. Bold is sequence where sgRNA
binds. Double strand break occurs at ˆˆˆˆˆˆ.

G41S: GGC to Be Changed to AGC

Western Blot Analyses

50 TAATTACACGCAGAGACCGGTCCCGCCTCTTTGACACA
GAAGTGACAAGGCAAAGCTCGCTCAACCAGCCCCCCAC
CCCGCCCCCCCAGCTCAACACAACAGCGGCTGCGCGGA
CAGCCCGCAGCCCTCACTTAAGATGGCGAAAGCTTCCT
CAGCCGCCCGCTCTTCTTCCTCAGGGAGGCGATCGGGC
CCGCCTCCCCGGGCGCCACAGTCGCGTGACCCGCACAA
TGGCTAACAGCCAACCTAAGGCTTCCCAGCAACGCCAA
GCAAAAGTCATGACCGCCGCCGCGGGCTCGGCGAGCC
GTGTTGCGGTGCCCTTATTGTTGTGTGCGCTGCTAGTG
CCCGGTGˆˆˆˆˆˆGCGCCTACGTGCTAGACGACTCCGACG
GGCTGGGCCGGGAGTTCGATGGCATCGGCGCAGTCAG
CGGCGGCGGGGTGAGCGCGGGCTGGCGGGAGGCAGGA
GTGCGGTGCGGCGCAGGGACCGCAGGGACCGCAGGGA
CCGCCGGGGCCGCCCCCTCCCACAAGCCCCCGCGGCGT
TGCCGGGCGAGCGCACGCCGCTTCCCCGCGCGCCGGG
GTGAGATGAACCCGGGCTGGCGGTTAGATTGCAATGGG
GAGCCAGGCGTCTCGAGGGGACAGGCGTCTGCTGCAG
TCAAGTGGCCCGGGCTCGAGGGAGCCCTCGTTCTGGAT
CGCCGGC-30

Total brain tissues were homogenized and prepared in RIPA
buffer supplemented with phosphatase and protease inhibitors.
Protein concentration analysis was determined with a BCA
protein assay kit (Thermo Fisher Scientific, Waltham, MA,
United States) according to manufacturer’s instructions. Samples
were prepared with 6x Laemmli buffer and lysis buffer. Twenty
five micrograms of protein were loaded per lane and separated
by 12% SDS-PAGE under denaturing conditions with a miniProtean II gel electrophoresis apparatus and included a Precision
Plus Standard Protein Dual color (Biorad) to enable identification
of band size. Separated proteins were then transferred to a
PVDF membrane. Non-specific binding sites on the membrane
were blocked with 5% skim milk in TBS-Tween 20 for 1 h
at room temperature. Primary antibodies against GALC (in
house produced monoclonal mouse IgG, 1:100 dilution), myelin
proteolipids (PLP, a kind gift from Robert Skoff, Wayne
University, rabbit IgG, 1:2,000 dilution), myelin basic proteins
(MBP, a kind gift from Anthony Campagnoni, UCLA; rabbit
IgG, 1:500 dilutiom), Actin (Sigma-Aldrich, rabbit, 1:2,000),
LAMP1, LAMP2 (Iowa Hybridoma Cell Bank, mouse IgG,
G41S Donor Template for HDR
0
1:500) and LC3 (Cell Signal, rabbit IgG, 1:500) were prepared
5 -TGACCGCCGCCGCGGGCTCGGCGAGCCGTGTTGCGG
◦
TGCCCTTATTGTTGTGTGCGCTGCTAGTGCCtGGTaGCGC in 5% milk in TBS/Tween 20 and incubated at 4 C overnight.
CTACGTGCTAGACGACTCCGACGGGCTGGGCCGGGAGTT Membranes were washed in TBST (0.05%) 3× for 5 mins
and incubated for 1 h at room temperature with secondary
CGATGGCATCGGCGCAGTCAGCGGCGGCGGG-30
KasI site was destroyed when the mutation was made, which antibody. Secondary antibodies were horseradish peroxidasecan be used to screen mice. PAM site was mutated to avoid cutting conjugated (HRP), diluted in 5% milk TBST, and then developed
donor template by guide (Silent Mutation P = CCC -> P = CCt). using the Odyssey CLx apparatus (Li-Cor). Protein band
densities were quantified using ImageJ and normalized by the
housekeeping protein GAPDH.
T513M: ACG Changed to ATG
50 -TACAGGCATCTGGTCAATTATTTGGATATATTTCCAAA
Immunohistochemistry
TACATCACACACACACACACACACACACCCTAAACTTTG
Mice were perfused with PBS under 5% isoflurane anesthesia
TTTCTAAGTATTATGTTTTATAAATTAGTCAAGTATTTCA
CAGTGTATCACCGATATCAGAAAGGAGAGATCTGGTAAG followed by 4% paraformaldehyde (PFA) before tissue was
GGCTTGCTAATCAGCCGCTGAGATACTAAGTGGAGGACT removed and processed for cryosectioning. Cryosections of 30
TACTTTTTGTGTTCTGAACAGAGTACCCACTTTTTAGTG
µm thickness were cut for immunohistochemistry (IHC). The
AAGCTCCGAATTTTGCTGATCAGACTGGCGTGTTTGAGT sections were blocked free-floating with blocking buffer (0.3
ACTACATGAATAATGAAGACCGTGAGCACCGCTTˆˆˆˆˆˆC
M glycine, 1% BSA, 5% normal donkey serum, 5% normal
goat serum, 0.30% Triton X-100, TBS) for 1 h at room
ACGCTGCGCCAAGTTCTCAACCAACGACCTATTACCTG
GGCTGCAGACGCTTCCAGCACAATCAGTGTTATAGGCGA temperature, followed by 24–72 h incubation at 4◦ C with
TCACCACTGGTGTGTGAGAGATGCCCTCAGTGTATACGC primary antibodies in blocking solution. After washing with
TBS, tissue was incubated with secondary antibodies at room
TTGCGATTTGGGGTACATTCTGAGTGAAGGGATTCCAA
TAGGCCGTCTCCTGTCAAGAACCTAATAGGTGGTGGGTC temperature for 1 h in blocking buffer and washed again in
TBS. Tissue was mounted with Prolong Gold antifade reagent
AGAATTATGTGACCTCAAGTGATCAAATTAGCTTCCATG
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data were reported as the peak area ratios of the psychosine to its
internal standard.

(cat# P36931 Life technologies, Eugene, OR, United States) and
visualized using confocal microscopy (Leica TCS SPE, Wetzlar,
Germany). Primary antibodies used included: GALC (in house
produced mouse IgG monoclonal, 1:100 dilution), PLP (a kind
gift from Robert Skoff, Wayne State Univ, rabbit IgG 1:2,000
dilution), GFAP (Millipore, Mouse, 1:1,000), IBA-1 (Millipore,
rabbit IgG 1:300), LAMP1 and LAMP2 (Iowa Hybridoma
Cell Bank, mouse IgG, 1:500). Secondary antibodies used
included: AlexaFluor 488 anti-Mouse (cat#A-11029, Thermo
Fisher Scientific, Waltham, MA, 1:500 dilution) and Dylight
549 anti-rat (cat# 112-506-068 (Jackson ImmunoResearch,
1:500 dilution). Counterstaining for cell nuclei was performed
with DAPI (40 ,6-diamidino-2-phenylindole, cat#D1306, Thermo
Fisher Scientific, Waltham, MA, 1: 3,000 dilutions in TBS).
Immunofluorescent complexes were visualized using a Leica TCS
SPE confocal laser with an upright DM5500Q Microscope (Leica
Biosystems Inc., Buffalo Grove, IL, United States). Counting
of GALC/Lamp double positive puncta were done by confocal
microscopy with an immersion oil 63x objective on four
random fields (n = 3 mice/condition) and Image J-Graph Pad
post hoc analyses.

Monoclonal β−Galactosyl−Ceramidase
Antibody Generation
Monoclonal mouse anti-GALC antibodies were generated with
the goal to recognize full-length human and mouse GALC
proteins in tissues and protein extracts. Monoclonals were
prepared following procedures described previously (Pfister et al.,
1989). In short, mice were immunized subcutaneously two
times with 25 µg of a keyhole limpet hemocyanin-conjugated
synthetic peptide encompassing aminoacids 469–498 of human
GALC (which shares >90% homology with the mouse protein
sequence), mixed with Gerbu adjuvant. Before 3 days of fusion,
the mice received an intravenous injection with 10 µg of antigen
together with adjuvant. Spleen and lymph node cells were fused
with SP2 myeloma cells to generate hybridomas. Positive clones
were selected and cloned by repeated screening against the GALC
protein using enzyme-linked immunosorbent assay (ELISA).
The performance and specificity of several antibody clones
were validated using western blot and immunofluorescence
microscopy against transfected cells.

β−Galactosyl−Ceramidase Activity and
Quantification of Glucosylsphingosine
and Psychosine

Disease Severity Score
The clinical conditions of the mice were assessed and quantified
using an expanded disease severity score (DSS) based on our
previous DSS system (Marshall et al., 2018). The new scoring
system takes into consideration the following general categories:
physical characteristics (weight loss, tremor, and kyphosis),
locomotion, wire hanging, and cerebellar function (hindlimb
clasping, ledge balance). Each individual test is scored as follows:
weight loss: compared to average of previous 2 weeks score of
0: 0.5 loss or less (including weight gain); score of 0.5: 0.5–
1 g loss; score 1: 1–1.5 g loss; score 1.5: 1.5–2 g loss; score
2: >2 g loss. Tremor score 0: no tremor; score; score 1: mild
tremor; score 2: severe tremor. Kyphosis score 0: no kyphosis
in any condition; score 1: kyphosis when hunched over; score
2: kyphosis when lying flat. Locomotion score 0: normal; score
0.5: awkward gait; score 1: waddling; score 1.5: one leg paralyzed;
score 2: both legs paralyzed. Wire hanging score 0: >45 s;
score 0.5: 31–45 s; score 1: 16–30 s; score 1.5: 5–15 s; score
2: 0–5 s. Hindlimb clasping score 0: none; score 0.5: one limb
partial (under 5 s out of 10); score 1: two limbs partial or 1
limb full (over 5 s out of 10); score 2: both limbs full. Ledge
balance score 0: no problems; score 0.5: minor problem (mouse
is reaching down and slips); score 1: minor fall (mouse is starting
to move down and falls); score 2: fall from ledge with no
attempt to get down.

Our methods have been described in detail in Marshall et al.
(2018). To summarize, a Vibra-cell ultrasonic liquid processor
model#VCX 130 (Sonics and Materials Inc., Newton, CT,
United States) was used to homogenize fresh frozen tissue in
water. Fluorescent GALC substrate (6HMU-beta-D-galactoside;
Moscerdam Substrates) was incubated with tissue lysates
(20 µg) for 17 h at 37◦ C before the reaction was stopped.
Fluorescence was measured to assess enzyme activity using a
Beckmann Coulter DTX 880 multimode detector (Beckman
Coulter, Brea, CA, United States) through excitation/emission
wavelengths of 385 and 450 nm, respectively. Methanol-acetic
acid solution (0.5% Acetic Acid in methanol) was used to extract
psychosine from tissue homogenates (brain and spinal cord
lysates) (200 µg). Psychosine content was then determined
by liquid chromatography-tandem mass spectrometry (LCMS/MS). To differentiate glucosylsphingosine vs psychosine, the
following protocol was used: mouse brains were homogenized
in 2% CHAPS solution (4 mL/g brain). Protein precipitation
was used to extract psychosine from 50 µL of homogenate
in the presence of d5-psychosine and d5-glucosylsphingosine
as internal standard for psychosine and glucosylsphingosine,
respectively. Quality control (QC) samples were prepared
by pooling 10% of extracts from study samples. The QC
samples were used to monitor the instrument performance
and injected every five study samples. Analysis of psychosine
and glucosylsphingosine was performed with a Shimadzu
20AD HPLC system coupled to a 4000QTrap mass spectrometer
equipped with an electrospray ion source and operated in positive
multiple reaction monitoring (MRM) mode (Sidhu et al., 2018).
Data processing was conducted with Analyst 1.6.3 (Applied
Biosystems). The relative quantification of psychosine and the
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Motor and Behavioral Tests
Latencies to fall in the rotarod below normal values were
considered pathognomonic and measured as described (Marshall
et al., 2018). Motor activity in the open field test was evaluated as
described (Kan et al., 2016; Nelvagal et al., 2021). Mice were tested
for anxiety using the light/dark box (Malmberg-Aiello et al.,
2002; Bourin and Hascoet, 2003). Spatial memory was evaluated
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WT as references of absence and normal presence of GALC
protein, respectively (Figures 1D–O). Remarkably, the analysis
showed reduced co-staining for GALCT 513M and GALCG41S
mutant proteins with Lamp2 (Figures 1F,I), suggesting partial
mislocalization with lysosomes. As expected, TWI mutants
had no immunodetectable GALC protein (Figure 1L) in
comparison with wild-type controls (Figure 1O). Quantification
of double positive GALC/LAMP-2 puncta showed ∼70% less
GALCT 513M /T 513M protein located in lysosomes (Figure 2A).
Interestingly, association of GALCG41S/G41S protein with LAMP2+ puncta was reduced at early times points (P25) but not in
older mice (P120, Figure 2A).
Next, we assessed how GALCT 513M/T 513 and GALCG41S/G41S
mutations impacted enzyme activity. As expected for an
infantile mutation, mice with the GALCT 513M/T 513 mutation
have undetectable enzyme activity in the brain, similar to levels
in the TWI mouse (Figure 2B). In contrast, analysis of GALC
activity in the brain of GALCG41S/G41S mice showed a small
reduction in enzyme activity (Figure 2B).
The loss of function of GALC enzyme in KD results in the
progressive accumulation of psychosine (Igisu and Suzuki,
1984; White et al., 2009; Spassieva and Bieberich, 2016). To
examine how these mutations impacted the accumulation
of psychosine, lipid extracts from P40 GALCT 513M/T 513 ,
GALCG41S/G41S , and TWI brain (Figure 2C) and sciatic
nerves (Figure 2D) were analyzed by LC-MS-MS. Consistent
with the lack of GALC activity, both GALCT 513M /T 513M
and TWI tissues have the highest levels of psychosine
(Figures 2C,D). In contrast, GALCG41S/G41S mice showed
psychosine levels similar to wild type in both central and
peripheral nerve tissue. To confirm the accumulation of
psychosine in GALCT 513M/T 513 mice, we measured the
relative levels of glucosylsphingosine and psychosine, using
a LC-MS/MS protocol to completely separate the isomeric
glucosylsphingosine and psychosine (glucosylsphingosine and
psychosine have the same m/z 462) (Figure 2E). As expected,
both TWI and GALCT 513M/T 513 mutants accumulate high
levels of psychosine, while glucosylsphingosine is only found
at trace levels (Figures 2E,F). Figure 2G shows the relative
abundance of psychosine and glucosylsphingosine in TWI and
GALCT 513M/T 513 brains versus WT brains, confirming that
only psychosine is accumulated in both mutants. Interestingly,
psychosine in TWI is higher than in GALCT 513M/T 513 brains.

using the Barnes and Morris water maze tests as described
(Patil et al., 2009).

Neural Precursor Cultures and
Starvation Model
Neural precursors were isolated from the subventricular zone
from P4 to 6 mice and stable self-proliferating cultures were
established as described (Felling et al., 2006; Givogri et al.,
2008). Cells were differentiated on poly-lysine coated coverslips
in defined medium containing 1% FBS for 7 days. Half of the
coverslips were replenished with complete medium containing
FBS and the other half with FBS-depleted medium. Starvation
(Mejlvang et al., 2018) was then maintained for 4 h before
cells were washed and fixed in 1.5% PFA/PBS for 30 min. Cells
were processed for double immunohistochemistry using antiLAMP-2 (see above) and anti-LC3 (see above) antibodies. After
mounting and nuclear staining using DAPI, confocal images
were taken using a 63x oil objective. Double LAMP-2+/LC3+
(i.e., colocalization and yellow fluorescence) and single LAMP2+ puncta were counted in 15–20 cells per condition.

Statistical Analysis
Prism 8 software (GraphPad Software Inc., La Jolla, CA,
United States) was used to prepare graphs and statistics.
One-way ANOVA with Gaussian distribution was performed
to analyze data with more than two means, with two-sided
p-values < 0.05 considered significant. T-tests were also
performed for the comparisons between two means, with
two-sided p < 0.05 considered significant. Graphs represent
the mean of independent measurements (with sample sizes
ranging n = 6–12) shown with errors bars representing standard
error of the mean.

RESULTS
Biochemically, GALCT 513M/T 513M and
GALCG41S/G41S Mice Largely
Recapitulate Early-Onset and Late-Onset
Krabbe Disease, Respectively

The presence of the GALCT 513M /T 513M and GALCG41S/G41S
mutations (Figure 1A) was confirmed by PCR analysis from
total genomic DNA (Figure 1B). Western blotting analysis of
protein extracts prepared from P25 brains indicated that mutated
GALC proteins are clearly expressed in both GALCT 513M/T 513
and GALCG41S/G41S mutants, although the GALCT 513M protein
appears to have a lower molecular weight (Figure 1C), which is
likely indicating abnormal glycosylation of the mutated protein.
Studies have previously reported that many point mutations in
the GALC protein alter the transport to the lysosomes (Lee et al.,
2010; Shin et al., 2016; Irahara-Miyana et al., 2018). To examine
whether this occurs in GALCT 513M/T 513 and GALCG41S/G41S
mutants, immunofluorescence confocal microscopy was used to
determine if the mutated GALC protein colocalized with the
lysosomal marker LAMP-2. Brain sections of both mutants were
analyzed at postnatal day 25 (P25), using aged-matched Twi and
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GALCT 513M/T513M and GALCG41S/G41S
Mice Develop Clinical and Motor
Phenotypes Consistent With Early-Onset
and Late-Onset Krabbe Disease,
Respectively
GALCT 513M/T 513 mice have a median survival of 46 vs
42 days in Twi mice (Figure 3A). The maximal survival of
GALCT 513M/T 513 was 49 ± 3 days. In contrast, GALCG41S/G41S
mice have no significant decrease in their survival, with all
mutants reaching adult age similar to WT mice (Figure 3A).
Expectedly, GALCT 513M/T 513 mice and GALCG41S/G41S mice
show remarkably different clinical signs of neurological disease.
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FIGURE 1 | Lysosomal localization of mutated GALC protein is reduced in GALCT513M/T513M and GALCG41S/G41S mice. (A) Localization of the G41S and T513M
mutations within the GALC gene. (B) PCR-based identification of mutations in GALCT513M/T513M and GALCG41S/G41S . Mutation in GALCtwi/twi and GALC+/+ were
used as references. (C) Western blot analysis of GALC protein lysates prepared from P40 brains. Actin was used for loading control. (D–O) Immunohistochemistry
on cryosections of P25 brain tissue showing colocalization of GALC protein (red) with LAMP-2 (green) in lysosomes of GALCT513M/T513M , GALCG41S/G41S ,
GALCtwi/twi , and GALC+/+ mice. DAPI, blue. Scale bar = 50 µm.
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FIGURE 2 | Analysis of mutated GALC activity and psychosine production in GALCT513M/T513M and GALCG41S/G41S mice. (A) Co-localization of GALC in lysosomes
was measured by confocal analysis of brain cortices of each genotype. Data represent the fraction (as%) of total GALC+ puncta that was co-stained with Lamp2+.
Counts were done on random areas of the brain cortex. (B) GALC activity was analyzed fluorometrically in protein extracts from P40 brains. (C,D) Psychosine levels
in P40 brains (C) and sciatic nerve (D) were measured by LC-MS-MS. (E–G) Chromatograms of glucosylsphingosine and psychosine in WT (E) and twitcher mouse
brains (F) were detected by mass spectrometry. The glucosylsphingosine and psychosine were measured as the fold changes in the brain of Twi and
GALCT513M/T513M mutants versus WT (G). Data represent the mean ± SEM of 4–6 mice/genotype, analyzed by ANOVA/Tukey’s post hoc test ∗ p < 0.05,
∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.001.

To further evaluate motor performance and balance,
GALCT 513M/T 513 and GALCG41S/G41S mice were trained using
an accelerating rotarod test. As expected for animals with a
severe neurological phenotype, P40 GALCT 513M/T 513 mice
showed a significantly impaired capacity to remain in the rotarod
(Figure 4). In contrast, GALCG41S/G41S mice had no significant
deficits in their latency to fall from the rod either when young
(P40) or older (P200 and P350) (Figure 4).
Next, we tested both mutants in the open field locomotor
test. Line crosses and time spent in center were both calculated
to examine motor behavior and anxiety. Figure 5A shows
that GALCT 513M/T 513 mice display a progressive decline in
mobility starting at P30. Exploratory and anxiety behaviors,
measured as the time that the animal spent in the center
quadrant of the open field, showed the expected reduced time
when GALCT 513M/T 513 mice became less mobile at P30 and
P40 (Figure 5B). However, younger P22 GALCT 513M/T 513 mice,
which showed no obvious mobility limitations, also displayed
a reduced time spent in the center quadrant. This suggests
early signs of decreased exploratory behavior and likely, elevated
anxiety in GALCT 513M/T 513 mice compared with wild type
mice (Figure 5B). In contrast, GALCG41S/G41S mice showed

Using our established DSS system (Marshall et al., 2018),
GALCT 513M/T 513 mice have an onset with significant increases in
DSS at postnatal day 24 (P24 ± 2 days). This is slightly delayed
in comparison with Twi mice, which show clinical onset at
P22 ± 2 days (Figure 3B). GALCT 513M/T 513 mice follow a typical
rapid and progressive increase in DSS, similar to TWI mice
(Figure 3B). In contrast, GALCG41S/G41S mice show DSS values
comparable to WT for most of their life until approximately
250 days, when minor but significant motor deficits were
measured (Figure 3B). In terms of body weight, GALCT 513M/T 513
mice and GALCG41S/G41S mice showed expected decreases and
normal gains, respectively (Figure 3C).
As expected for a severe demyelinating phenotype,
GALCT 513M/T 513 mice showed increased tremor by P40
(Figure 3D). GALCG41S/G41S mice did not have detectable
tremor at any time point in our study (Figure 3D). Assessment
in the ledge test showed an early deficit in GALCT 513M/T 513
mice at ∼P40 (Figure 3E). Interestingly, GALCG41S/G41S mice
did not have measurable deficits in this test until they reached
adulthood (P250–350) (Figure 3E). Similarly, a positive clasping
test was detected in ∼P40 GALCT 513M/T 513 mice and only in
aged (>P250) GALCG41S/G41S mice (Figure 3F).
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FIGURE 3 | Clinical analysis of GALCT513M/T513M and GALCG41S/G41S mice. Survival (A), disease severity score (DSS) (B), body weight (C), onset of body tremor
(D), onset of errors on the ledge test (E), and onset of affected clasp reflex (F) were measured for each genotype. n.d., non-detected; †, dead. n = 6–8
mice/genotype/time point. *p < 0.05.

Spatial Learning Deficiencies Introduced
by the G41S Mutation
The open field test showed increased exploratory behaviors
of GALCG41S/G41S mice. We wanted to investigate this in
more detail by testing their response to the dark-light box.
GALCG41S/G41S mice were tested at 180, 220, and 350 days
of age showing similar average time spent exploring the dark
compartment, although younger P180 GALCG41S/G41S mice
spent less time in the darkness (Figure 6A). Remarkably, when
the latency to enter the dark box was measured, GALCG41S/G41S
mice showed increased times spent in the lighted box at every
time point (Figure 6B).
To assess whether spatial learning and memory functions are
impacted in GALCG41S/G41S mice, mice were tested in the Barnes
and Water Morris maze tests. Interestingly, both homozygous
and heterozygous mice for the GALCG41S/G41S mutation showed
higher latencies to find their target in the Barnes test, in
contrast to wild type littermates which rapidly learned where
the target was (Figure 6C). This might be supported by the
lack of significant differences in poking the target (Figure 6D)
or opposite (Figure 6E) holes. While there were no significant
differences in the percentage of pokes in target and opposite
holes, all genotypes spent more time exploring the target hole
(∼20%) than the opposite hole (∼5%) (Figures 6D,E). When
tested in the Morris water maze, all genotypes showed similar

FIGURE 4 | GALCT513M/T513M but not GALCG41S/G41S mice exhibit rotarod
deficits. Rotarod performance was significantly lower in GALCT513M/T513M
mutants. Results are expressed as latency to fall in seconds (sec). Mice were
tested at P40, P200, and P350. Data represent the mean + SEM of
n = 6/group, analyzed by ANOVA/Tukey’s post hoc test ∗∗∗ p < 0.01.

similar motor activities as per line crossing to wild type mice
(Figure 5C). Interestingly, GALCG41S/G41S mice showed higher
time spent in the center quadrant at each time point of the
study (Figure 5D).
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FIGURE 5 | Distinct exploratory behavior and anxiety-type responses exhibited by GALCT513M/T513M but not GALCG41S/G41S mice in the open field test.
(A) Progressive loss of motor exploratory activity (measured as number of lines crossed) was observed in GALCT513M/T513M mice, starting at 30 days. (B) Signs of
increased anxiety type responses (measured as time spent in the center quadrant) in GALCT513M/T513M mice were detected immediately after weaning.
(C) GALCG41S/G41S mice exhibited normal motor activity at all time points. (D) GALCG41S/G41S mice showed signs of reduced anxiety-type behavior. Data represent
the mean + SEM of n = 6–8/group, analyzed by ANOVA/Tukey’s post hoc test ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.005.

learning capacity to find the platform (Figure 6F). Likewise,
no significant differences were observed in the number of
annulus crossings between GALCG41S/G41S and wild-type mice
(Figure 6G). However, both homozygous GALCG41S/G41S and
heterozygous GALCG41S/+ mice showed a significant decrease
in the number of crossings over the same exact location on the
platform compared with wild-type controls (Figure 6H).

in TWI brains. In contrast, while the level of PLP staining
seemed undisturbed in P40 GALCG41S/G41S mice (Figure 7C),
it clearly showed signs of patchy demyelination by 2 years
(Figure 7D). Examination at intermediate time points (P180
and P350) showed PLP staining comparable to WT (data not
shown), suggesting that central demyelination is a late event
in GALCG41S/G41S mice. Loss of myelin was confirmed by
measuring PLP (Figures 7G,I) and MBP (Figures 7H,J) levels
on semiquatitative western blotting from P40 GALCT 513M/T 513M
and 2y GALCG41S/G41S total brain extracts.
Peripheral myelination also showed contrasting patterns
of damage in GALCT 513M/T 513M and GALCG41S/G41S mice.
Toluidine blue staining of sciatic nerve cross sections indicated
high levels of peripheral demyelination (i.e., reduced thickness or
complete loss of myelin sheaths in axonal profiles), edema (i.e.,
loss of packed myelinated axons, with swelling of extracellular
spaces), and inflammation (i.e., presence of macrophagic profiles
within the nerve) in the nerves of P40 GALCT 513M/T 513M
(Figure 8A) comparable to age-matched P40 TWI nerves
(Figure 8D). In contrast, early (P40, Figure 8B) or aged (2y,
Figure 8C) nerves from GALCG41S/G41S mice did not show
significant signs of demyelination or damage. Figures 8E,F

Neuropathology in the Brains of
GALCT 513M/T 513M and GALCG41S/G41S
Mice
To examine central myelination, brain cryosections were stained
for myelin proteolipids (PLP). We focused on the corpus
callosum, a structure that is heavily demyelinated in the TWI
brain at P40 (Figure 7E, compare with control levels in
Figure 7F). GALCT 513M /T 513M and GALCG41S/G41S mice showed
distinct patterns of central demyelination. GALCT 513M/T 513M
mice displayed the expected rapid and severe demyelination for
a short lived leukodystrophic condition at P20 (Figure 7A) and
P40 (Figure 7B) brains. Interestingly, demyelination appeared
patchy in contrast to more global and diffuse damage observed
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FIGURE 6 | Cognitive capacity and spatial learning performance are slightly impaired in GALCG41S/G41S mice. (A,B) Activity of GALCG41S/G41S mice in the dark-light
box showed slightly less time spent exploring the dark compartment in younger (P180) vs aged older (P220, P350), with an increased latency to enter in the dark
box at all time points. Data represent the mean + SEM of n = 4–6/group, analyzed by ANOVA/Tukey’s post hoc test ∗ p < 0.05. (C–E) The Barnes maze test showed
GALCG41S/G41S and GALCG41S/+ mice increased times to identify the target hole (C), with no significant differences in the percentage of pokes in target (D) vs
opposite (E) holes. Data represent the mean + SEM of n = 6/group, analyzed by ANOVA/Tukey’s post hoc test ∗ p < 0.05. (F–H) The Morris water maze test
measured no significant differences in the escape latency (F) and annulus crossings (G) but significant decreases in the number of platform crossings in both
GALCG41S/G41S and GALCG41S/+ mice. Data represent the mean + SEM of n = 6–8/group, analyzed by ANOVA/Tukey’s post hoc test ∗∗ p < 0.01.
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FIGURE 7 | GALCT513M/T513M and GALCG41S/G41S mice exhibit signs of early and late central demyelination. Confocal microscopy after immunohistochemistry
using anti-PLP detected reductions of PLP (in green) expression in the corpus callosum of GALCT513M/T513M mice at P20 (A) and P40 (B), which are comparable to
demyelination observed in P40 TWI (E). In contrast, demyelination (indicated as a reduction of PLP immunofluorescence) was less evident at P40 (C), and patchy in
the 2 year old (D) GALCG41S/G41S corpus callosum. (F) shows PLP staining in P40 GALC+/+ corpus callosum. Blue: DAPI. Bar = 50 mm. (G–J) Semiquantitation of
myelin PLP and MBP levels (by western blotting) in whole brain extracts. Data represent the mean + SEM of n = 4–6/group, analyzed by ANOVA/Tukey’s post hoc
test ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.005.

and P40 (Figure 10B) GALCT 513M/T 513M mice. In contrast,
white matter areas in the brain of GALCG41S/G41S mice have
weaker immunoreactions for LAMP-1, with levels (Figure 10C)
comparable with WT (Figure 10F) at P40 and moderately
increased in 2y GALCG41S/G41S mice (Figure 10D). Increase
of LAMP-1 was confirmed on semiquatitative western blotting
from P40 GALCT 513M/T 513M and 2y GALCG41S/G41S total brain
extracts (Figures 10G,H).
We and others have indicated deficiencies in the autophagic
function in TWI mice (Ribbens et al., 2014; Del Grosso
et al., 2019, 2022; Lin et al., 2020). To evaluate whether
autophagy is also defective in the new GALCT 513M/T 513M
and GALCG41S/G41S mice, subventricular zone-derived neural
progenitor cultures (Felling et al., 2006; Givogri et al.,
2008) were starved for 4 h (Mejlvang et al., 2018) before
double immunocytochemistry for LC3 and LAMP-2. In normal
conditions, starvation promotes autophagy which can be detected
by increased fusion of autophagosomes with lysosomes as seen
with WT cells (Figures 10I,J). As expected, TWI cells have
increased production of lysosomes and autophagosomes, which
remain largely segregated even when cells underwent starvation
(compare Figure 10N with naïve cells in inset N1). Likewise, the
basal level of LAMP-2+ lysosomes and LC3+ autophagosomes in
naïve (non-starved) GALCT 513M/T 513M cells is clearly increased
(Figure 10K). Starvation only worsens this situation without
significant fusion of both organelles (Figure 10L). Instead,
formation of autophagolysosomes after starvation seems less
compromised in GALCG41S/G41S cells (Figure 10M, compare
with naïve GALCG41S/G41S cells, inset M1). Quantification
of double labeled LC3+/LAMP-2+ puncta (as a percentage
from the total number of LAMP-2+ puncta) confirmed these
observations in starved cell cultures (Figure 10O).

show P40 and 2y WT nerves. These results suggest that both
new mutants undergo distinct patterns of demyelination: while
GALCT 513M/T 513M mice suffer from rapid central and peripheral
demyelination, GALCG41S/G41S mice undergo mostly, if not
solely, a late-onset central demyelination, without major impact
on peripheral nerves.
Inflammation was evaluated by immunostaining for GFAP
and IBA-1, which identify activated astrocytes (Brenner,
2014) and microglia (Norden et al., 2016). As expected,
GFAP+ astrogliosis was markedly increased in the brain of
P40 GALCT 513M/T 513M mice (Figure 9B), to levels comparable
to those observed in P40 TWI (Figure 9E). Astrogliosis
was also detectable in younger P20 GALCT 513M/T 513M mice
(Figure 9A), suggesting that inflammatory responses start
early in the nervous system of GALCT 513M/T 513M mice.
Astrocyte responses in GALCG41S mice were weaker than in
GALCT 513M/T 513M mice, with detectable GFAP+ astroglia in 2y
GALCG41S/G41S mice (Figure 9D). At earlier ages (P40), GFAP
staining in GALCG41S/G41S and WT brains was indistinguishable
(Figures 9C,F). Interestingly, IBA-1 immunostaining was less
intense in both mutants (Figures 9G–J) compared with the high
levels detected in the P40 TWI brain (Figure 9K). Figure 9L
shows IBA-1 in WT.

Distinct Autophagolysosomal Responses
in GALCT 513M/T 513M and GALCG41S/G41S
Alterations in lysosomal biogenesis are characteristic findings
in KD (Marshall et al., 2018). This can be detected by
increased expression of the lysosomal marker LAMP-1, as
shown in the P40 TWI brain (Figure 10E). Immunostaining
of LAMP-1 showed very intense signals in all white matter
areas such as the corpus callosum in both P20 (Figure 10A)
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FIGURE 8 | GALCT513M/T513M but not GALCG41S/G41S mice exhibit signs of peripheral demyelination. Toluidine blue staining on plastic cross sections of sciatic
nerves showed pronounced demyelination and edema in nerves from P40 GALCT513M/T513M mice (A), comparable to damage observed in nerves from age
matched TWI mice (D). In contrast, no significant damage to myelin was detected in nerves from either P40 (B) or 2 y-old (C) GALCG41S/G41S mice. (E,F) cross
sections of P40 and 2y WT sciatic nerves. Bar = 20 µm.

GALCT 513M/T 513M mice show clinical signs of an early
neurological condition, with onset of motor and behavioral
declines at ∼P24. Mutant mice rapidly progress into stereotypic
manifestations of a severe leukodystrophy, with body weight loss,
twitching, tremor, and eventually death by the 7th week of life.
This mutation is present in many infant patients of European
ancestry, contributing to ∼10% of infant forms of KD (Kleijer
et al., 1997). These patients show early-onset motor declines
and premature death. Homozygous mice for GALCT 513M/T 513M
displayed the expected progression, and thus, constitute a newly
engineered but genuine model for infantile KD, matching a
severe mutation found in human patients. While the TWI mouse
has been historically used as a model for infantile KD, it is
more of a surrogate model for the 30 kb deletion found in
infantile patients (Kleijer et al., 1997), because the deficiency of
GALC activity in TWI mice is due to the absence of detectable
GALC protein. In contrast, the new GALCT 513M/T 513M mouse

LAMP-1 immunostaining in neuronal rich areas such as
the hippocampus was markedly low in the GALCT 513M/T 513M
brain (Figure 11C), with patterns and levels comparable
with WT (Figure 11D). In contrast, there was an apparent
increase in LAMP-1+ puncta in aged GALCG41S/G41S neurons
(Figure 11B box) compared to levels observed at younger ages
(Figure 11A box).

DISCUSSION
This study presents two new murine KD models carrying point
mutations T513M, frequent in human patients with infantile
forms of KD (Wenger et al., 1997), and G41S, found in many
adult forms of KD (Lissens et al., 2007). The new mutants were
generated using CRISPR-Cas9 gene editing and show remarkably
reproducible phenotypes, with viable carrier breeders.
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FIGURE 9 | Inflammatory responses in the brain of GALCT513M/T513M and GALCG41S/G41S mice. Immunohistochemistry using anti-GFAP (A–F) and anti-IBA-1
(G–L) antibodies detected gliotic responses (in green) in the corpus callosum and hippocampus of GALCT513M/T513M and GALCG41S/G41S mice. Confocal
microscopy showed that GFAP+ astroglial cells were comparable to those observed in TWI mice (E). In contrast, IBA-1+ cells were less abundant in either mutant
than in TWI mice (K). Bar = 50 µm, except in panel (K), where is 100 µm.

presents with a clinical disease that recapitulates that of the
TWI but with detectable protein both by western blotting and
immunohistochemistry.
Mice with the GALCG41S mutation showed normal postnatal
development, with no apparent compromise in survival, minimal
changes in motor skills, and some alterations in anxiety-type
behaviors measurable in aged (>P250) mutants. Patients with
this mutation usually present with adult onset manifestations,
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with less neurological compromise, at least during the first several
years of life (Lissens et al., 2007). Thus, the GALCG41S/G41S
mutant represents a genuine genetic model recapitulating many
aspects of adult-onset KD.
The effects of each mutation on enzymatic activity and
lysosomal translocation were remarkably different. In vitro
studies have reported how different point mutations in the GALC
gene can affect not only the activity, but also its trafficking to
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FIGURE 10 | Increased Expression of LAMP-1 in White Matter Areas of GALCT513M/T513M and GALCG41S/G41S Mice and Decreased Autophagolysosome Fusion in
Cultured Neural Precursors Immunohistochemistry using anti-LAMP-1 antibodies (in red) was used to evaluated lysosomal responses in white matter areas. Confocal
microscopy detected very robust increases of LAMP-1 expression in interfascicular oligodendrocytes in white matter areas like the corpus callosum in P20 (A) and
P40 (B) GALCT513M/T513M mice, to levels observed in TWI mice (E). In contrast, LAMP-1 expression in GALCG41S/G41S oligodendrocytes was increased in aged
mutants (D), but not in younger P40 (C) mice. (F) shows LAMP-1 staining in P40 GALC+/+ corpus callosum. Blue stain: DAPI. Bar = 50 µm. (G,H) Semiquantitation
of LAMP-1 levels (by western blotting) in whole brain extracts. Data represent the mean + SEM of n = 4/group, analyzed by ANOVA/Tukey’s post hoc test ∗ p < 0.01;
ns, not significant. (I–L) WT (I,J) and GALCT513M/T513M (K,L) cells were fed with our without (starved) 1% FBS for 4 h before double staining for LAMP-2 (red) and
LC3 (green). (M,N) GALCG41S/G41S (M) and TWI (N) cells were also starved for 4 h before immunocytochemistry. Insets show naïve cells, respectively. (O) Confocal
images were used for counting the total number of LAMP-2+ puncta and the number of double labeled LC3+/LAMP-2+ puncta. Data represent the mean + SEM of
15–20 cells/group, analyzed by ANOVA/Tukey’s post hoc test ∗ p < 0.05, ∗∗∗∗ p < 0.001.

and steric hindrance (Deane et al., 2011). In vitro studies have
shown that this change not only effectively abolishes GALC
activity but also largely blocks the mutated protein from reaching

the lysosome (Shin et al., 2016; Irahara-Miyana et al., 2018).
The GALCT 513M mutation changes a polar side chain to a
hydrophobic side chain with loss of stabilizing hydrogen bond
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FIGURE 11 | Increased expression of LAMP-1 in aged GALCG41S/G41S neurons. Confocal microscopy after immunohistochemistry using anti-LAMP-1 antibodies (in
red) was used to evaluated lysosomal responses in hippocampal neurons. Lamp1 expression was not significantly affected in either P40 GALCG41S/G41S (A) or P40
GALCT513M/T513M (C) neurons. However, larger Lamp1+ puncta were detected in 2 year-old GALCG41S/G41S neurons (B), in comparison to control levels (D). Blue:
DAPI. Bar = 50 µm.

The new KD mutants show interesting and chronologically
different neuropathological changes. A direct correlation between
toxic accumulations of psychosine and levels of demyelination,
astrogliosis, and microglial dysfunction in the nervous system of
the TWI mouse is well established (Ohno et al., 1993; Taniike
and Suzuki, 1994; Giri et al., 2008; Kondo et al., 2011; Claycomb
et al., 2014; O’Sullivan and Dev, 2015). As expected, these
three neuropathological responses started at onset of clinical
signs in GALCT 513M/T 513M mutants and worsened as disease
progressed. Demyelination, while impacting all levels of white
matter in the nervous system of GALCT 513M/T 513M mutants,
appeared patchy and less diffuse than that observed in TWI
mice, which may indicate undergoing segmental demyelination.
Whether there is remyelination ongoing to repair demyelination
is currently one area of study in our laboratory. In contrast,
central demyelination and gliosis in GALCG41S/G41S mutants
were evident only in older mutants, consistent with late-onset
neuropathology of adult forms of KD. Peripherally, both mutants
also show different patterns of demyelination, which was clearly

the lysosomal compartment (Shin et al., 2016). Aligned with this,
enzyme activity and localization analyses in our study show that
the GALCT 513M/T 513M mutated protein lacks detectable enzyme
activity, and a large fraction of the protein remains outside of the
lysosomal compartment.
The GALCG41S mutation introduces a polar side chain in
the TIM barrel domain of the 50 kDa GALC subunit (Lissens
et al., 2007; Deane et al., 2011; Spratley et al., 2016; Hill et al.,
2018), and thus should have minimal effect on the catalytic
site or to induce major protein misfolding impairing transport
to lysosomes (Shin et al., 2016). In fact, our in vivo studies
show that >80% of GALCG41S immunodetectable protein colocalized with Lamp2+ puncta, retaining significant residual
enzyme activity. Likely, the translocation of GALCG41S enzyme
residual activity to lysosomes explains the lower accumulation
of psychosine in this mutant. In contrast, the GALCT 513M/T 513M
mutants, which have poor lysosomal translocation of a mutated
protein without residual enzyme activity, accumulated high levels
of psychosine, comparable with levels measured in TWI mice.
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detected in sciatic nerves from GALCT 513M/T 513M mutants but
absent in GALCG41S/G41S nerves. The different involvement of
central and peripheral nerve damage in these mutants clearly
and quantifiably place the two models into the early-onset
(GALCT 513M/T 513M ) and late-onset (GALCG41S/G41S ) categories.
Behavioral examination of both mutants showed clear
indications of early (GALCT 513M/T 513M ) vs late (GALCG41S/G41S )
motor involvement. GALCT 513M/T 513M mutants showed
stereotypic motor declines comparable to those measured in
TWI mice (Olmstead, 1987). All motor readouts, including grip
strength, ledge walking, rotarod, and open field tests indicated
a progressive neurological involvement of motor pathways,
leading to severe and rapid paralysis. On the other hand,
GALCG41S/G41S mutants showed mild and late onset deficits in
some of the motor tests measured in our study. Interestingly,
GALCG41S/G41S mutants showed alterations in behavioral aspects
involving exploratory activities and anxiety-related responses.
Particularly, GALCG41S/G41S mutants showed increased times
involving exploratory activities in the open field, light/dark box,
and the Barnes maze tests. This may suggest that GALCG41S/G41S
mutants are less anxious, and/or more curious. There are very
few studies that have studied cognitive aspects on in KD, with
most research focused on infantile cases and fewer on adult-onset
cases (Patrick and Wilson, 1972; Crome et al., 1973; Loonen
et al., 1985; Olmstead, 1987; Kolodny et al., 1991; Jardim et al.,
1999; Debs et al., 2013; Xia et al., 2020; Yoon et al., 2021). In
general, most neurodevelopmental deficits in KD have been
associated with the loss of myelin and motor skills, which
undoubtedly impacts on the capacity of the patient to reach
neurodevelopmental milestones. The GALCG41S mutation,
which appears to trigger mild and later onset demyelination
(Saavedra-Matiz et al., 2016), with minimal involvement of motor
and learning skills, shows unexpected anxiolytic effects, at least in
some exploratory tasks. Interestingly, changes in social behavior
have been described occasionally in KD carriers (Christomanou
et al., 1981). Considering that KD is a recessive trait, manifested
only in homozygosis, the presence of subtle behavior changes
in carriers of the GALCG41S mutation may suggest some level
of phenotypic variation in adult-onset KD, at least with some
mutations. Defects in remyelination in heterozygous carriers of
the twitcher mutation have been described (Scott-Hewitt et al.,
2017, 2020), but nothing is known about the effects of GALC
haploinsufficiency on cognition. Understanding the cause for
these behavioral alterations is an exciting field of study which
is under further examination in our laboratory, as it may be
relevant to understand phenotypic manifestations reported in
carriers for this and other rare conditions (Christomanou et al.,
1980, 1981; Cheung and Ewens, 2006).
Impairment in lysosomal activity has been previously reported
in several LSDs, with responses involving the proliferation
of lysosomes (Napolitano et al., 2015; Sambri et al., 2017).
Indeed, the TWI nervous system is characterized by an increased
accumulation of lysosomes, detected by their high expression
of LAMP-2 (Marshall et al., 2018) and by defective autophagy
(Ribbens et al., 2014; Del Grosso et al., 2019, 2022). Both
new mutants showed increased expression of lysosomal markers
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in the brain, although with marked differences. Expression of
LAMP-1 is robustly upregulated in white matter in the brain
of the GALCT 513M /T 513M mutant since the onset of disease. In
contrast, lysosomal responses in the GALCG41S/G41S mutant in
white matter areas are low and only detected in aged mutants.
Aligned with results measured in TWI cells (Ribbens et al.,
2014; Del Grosso et al., 2019, 2022), GALCT 513M/T 513M and
GALCG41S/G41S cells also showed severe (GALCT 513M/T 513M )
and mild (GALCG41S/G41S ) defects in autophagic responses to
starvation. Interestingly, aged GALCG41S/G41S mutant neurons
showed larger LAMP-1+ puncta, indicative of a late-onset
lysosomal dysfunction in this mutant. This late-onset lysosomal
response may undermine cellular functions in GALCG41S/G41S
mutant neurons and lead to -some- of the observed alterations
in exploratory behavior in these mice. Clinical manifestations
affecting behavior and cognition have been described in several
inborn errors of the metabolism (Gutschalk et al., 2004;
Cox, 2020). Whether the GALCG41S mutation, and perhaps
others, affecting the GALC gene directly or indirectly impact
the structure and/or activity of synapses of neural networks
involved in higher cognitive functions remains an open question
(Castelvetri et al., 2011; Cantuti Castelvetri et al., 2013; CantutiCastelvetri and Bongarzone, 2016; Marshall and Bongarzone,
2016; Gowrishankar et al., 2020; Rebiai et al., 2021) and is the
subject of a follow up study in our laboratories. In addition
to changes in the metabolism of psychosine, other factors such
as accumulation of additional metabolites like lactosylceramide
(Papini et al., 2022), alteration of other signaling pathways
following lipid raft rearrangements in membranes (White et al.,
2009; Sural-Fehr et al., 2019; Belleri and Presta, 2022), abnormal
microglia-mediated synaptic pruning (Sellgren et al., 2019), could
be also contributors to changes in behavioral responses.
The new GALCT 513M/T 513M and GALCG41S/G41S murine
models described in this study offer contrasting yet unique
opportunities to study pathogenic mechanisms affecting synaptic
and myelin function and their contribution to the spectrum
of phenotypes observed in KD. These new transgenic lines
appear as bona fide models of infantile and adult-onset KD,
with evident advantages for their use in pre-clinical therapeutic
studies. Importantly, this study shows the potential of using
CRISPR-Cas9 gene editing to introduce and study functional
effects of other pathogenic mutations in cis or trans with specific
single nucleotide polymorphisms (SNPs) described in the GALC
gene (Saavedra-Matiz et al., 2016). For example some SNPs such
as p.I546T, while not pathogenic per se, are known to modify the
overall GALC activity when segregated with point mutations such
as T513M. This gene editing approach will likely be crucial to help
understand genotype-phenotype correlations and mechanisms
defining an early vs a late manifestation of Krabbe disease.
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